Clinical Trials

Showing trials with last updates posted in 2026.

NCT03784326 | ACTIVE_NOT_RECRUITING | PHASE2
43 participants

Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2019-02-19
Completion:
2026-12-31
Conditions
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT03180502 | ACTIVE_NOT_RECRUITING | PHASE2
120 participants

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2018-01-23
Completion:
2026-07-13
Conditions
  • Anaplastic Astrocytoma
  • Anaplastic Oligoastrocytoma
  • Anaplastic Oligodendroglioma
  • Diffuse Astrocytoma
  • Glioma
  • Oligoastrocytoma
  • Oligodendroglioma
  • WHO Grade 3 Glioma
Interventions
  • PROCEDURE
  • RADIATION
  • OTHER
  • DRUG
No Results Yet
NCT02506933 | ACTIVE_NOT_RECRUITING | PHASE2
102 participants

Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2015-12-21
Completion:
2018-01-25
Conditions
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Acute Lymphoblastic Leukemia in Remission
  • Acute Myeloid Leukemia in Remission
  • Chronic Lymphocytic Leukemia
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Cytomegaloviral Infection
  • Hodgkin Lymphoma
  • Lymphadenopathy
  • Lymphoblastic Lymphoma
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Myeloproliferative Neoplasm
  • Non-Hodgkin Lymphoma
Interventions
  • OTHER
  • BIOLOGICAL
NCT02208362 | ACTIVE_NOT_RECRUITING | PHASE1
65 participants

Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2015-05-18
Completion:
2021-02-08
Conditions
  • Recurrent Glioblastoma
  • Recurrent Malignant Glioma
  • Recurrent WHO Grade II Glioma
  • Recurrent WHO Grade III Glioma
  • Refractory Glioblastoma
  • Refractory Malignant Glioma
  • Refractory WHO Grade II Glioma
  • Refractory WHO Grade III Glioma
Interventions
  • BIOLOGICAL
  • OTHER
  • PROCEDURE
Previous
Sorted by latest updates
Next
Showing 40 trials per page